Correction

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US (vol 40, pg 699, 2022)

Journal

PHARMACOECONOMICS
Volume -, Issue -, Pages -

Publisher

ADIS INT LTD
DOI: 10.1007/s40273-023-01263-w

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available